How Epstein-Barr virus envelope glycoprotein gp350 tricks the CR2? A molecular dynamics study

被引:0
|
作者
Bingöl, Elif Naz [1 ]
Taştekil, Ilgaz [1 ]
Yay, Cansu [2 ]
Keskin, Nursena [2 ]
Ozbek, Pemra [2 ]
机构
[1] Department of Bioengineering, Institute of Pure and Applied Sciences, Marmara University, Istanbul, Turkey
[2] Department of Bioengineering, Faculty of Engineering, Marmara University, Istanbul, Turkey
关键词
Molecular dynamics;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Epstein–Barr Virus: Evaluation of gp350 and EBNA2 Gene Variability
    T. V. Solomai
    M. V. Malakhova
    E. A. Shitikov
    D. A. Bespyatykh
    V. A. Veselovskii
    T. A. Semenenko
    D. I. Smirnova
    A. V. Gracheva
    E. B. Faizuloev
    Molecular Genetics, Microbiology and Virology, 2022, 37 : 138 - 145
  • [22] Expression and immunogenic characterization of recombinant gp350 for developing a subunit vaccine against Epstein-Barr virus
    Wang, Man
    Jiang, Shuai
    Han, Zhenwei
    Zhao, Bing
    Wang, Li'ao
    Zhou, Zhixia
    Wang, Yefu
    APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2016, 100 (03) : 1221 - 1230
  • [23] Expression and immunogenic characterization of recombinant gp350 for developing a subunit vaccine against Epstein-Barr virus
    Man Wang
    Shuai Jiang
    Zhenwei Han
    Bing Zhao
    Li’ao Wang
    Zhixia Zhou
    Yefu Wang
    Applied Microbiology and Biotechnology, 2016, 100 : 1221 - 1230
  • [24] Identification of three gp350/220 regions involved in Epstein-Barr virus invasion of host cells
    Urquiza, M
    Lopez, R
    Patiño, H
    Rosas, JE
    Patarroyo, ME
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (42) : 35598 - 35605
  • [25] The Epstein-Barr virus (EBV) major envelope glycoprotein gp350/220-specific antibody reactivities in the sera of patients with different EBV-associated diseases
    Xu, JW
    Ahmad, A
    Blagdon, M
    D'Addario, M
    Jones, JF
    Dolcetti, R
    Vaccher, E
    Prasad, U
    Menezes, J
    INTERNATIONAL JOURNAL OF CANCER, 1998, 79 (05) : 481 - 486
  • [26] SOLUBLE GP350/220 AND DELETION MUTANT GLYCOPROTEINS BLOCK EPSTEIN-BARR VIRUS ADSORPTION TO LYMPHOCYTES
    TANNER, J
    WHANG, Y
    SAMPLE, J
    SEARS, A
    KIEFF, E
    JOURNAL OF VIROLOGY, 1988, 62 (12) : 4452 - 4464
  • [27] Isolating the Epstein-Barr virus (EBV) gp350/220 binding site on complement receptor type 2 (CR2/CD21) using site-directed mutagenesis
    Hannan, Jonathan P.
    Young, Kendra A.
    Szakonyi, Gerda
    Klein, Michael
    Chen, Xiaojiang S.
    Holers, V. Michael
    MOLECULAR IMMUNOLOGY, 2007, 44 (1-3) : 180 - 181
  • [28] Structure of the Epstein-Barr virus major envelope glycoprotein
    Szakonyi, Gerda
    Klein, Michael G.
    Hannan, Jonathan P.
    Young, Kendra A.
    Ma, Runlin Z.
    Asokan, Rengasamy
    Holers, V. Michael
    Chen, Xiaojiang S.
    NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2006, 13 (11) : 996 - 1001
  • [29] Structure of the Epstein-Barr virus major envelope glycoprotein
    Gerda Szakonyi
    Michael G Klein
    Jonathan P Hannan
    Kendra A Young
    Runlin Z Ma
    Rengasamy Asokan
    V Michael Holers
    Xiaojiang S Chen
    Nature Structural & Molecular Biology, 2006, 13 : 996 - 1001
  • [30] Infectious Epstein-Barr virus lacking major glycoprotein BLLF1 (gp350/220) demonstrates the existence of additional viral ligands
    Janz, A
    Oezel, M
    Kurzeder, C
    Mautner, J
    Pich, D
    Kost, M
    Hammerschmidt, W
    Delecluse, HJ
    JOURNAL OF VIROLOGY, 2000, 74 (21) : 10142 - 10152